Agilent Technologies Signs Co-Marketing Agreement with MRM Proteomics to Advance Quantitative Proteomics Solutions

SANTA CLARA, Calif. -- Agilent Technologies Inc. (NYSE: A) today announced it has extended a co-marketing agreement with MRM Proteomics Inc., a leading provider of advanced protein quantitation, biomarker and proteomic services. The agreement expands on an existing collaboration established in 2012 and will allow both organizations to bolster their combined proteomics solutions, comprising reagent [...]

New Phenomenex GC Column Set for Chlorinated Pesticides Runs Seven EPA Methods

Torrance, CA -- Phenomenex Inc., a global leader in the research and manufacture of advanced technologies for the separation sciences, introduces Zebron™ ZB-CLPesticides-1 and 2 for dual-column pesticide testing by GC/ECD (electron capture detection). This column set saves time and money for chlorinated pesticide testing commonly performed by environmental and drinking water testing labs, which [...]

New Handheld Radiation Detector Offers Enhanced Threat Detection, Identification

Security professionals who are responsible for ensuring public safety by detecting, locating and identifying radiological threats can now simplify and accelerate their work using a new handheld radiation detector with nuclide identification capabilities. The instrument, the Thermo Scientific RadEye SPRD (Spectroscopic Personal Radiation Detector), builds on the success of previous generations of Thermo Scientific radiation [...]

Philips to expand technology platforms for near patient diagnostic testing with acquisition of Unisensor

Amsterdam, the Netherlands and Allerød, Denmark – Royal Philips (NYSE: PHG; AEX: PHIA) today announced that it has signed an agreement to acquire Unisensor, an innovator in the field of optical analysis of fluids for diagnostic applications in health care, as well as other industries. The Unisensor technology and team will strengthen Philips’ innovation capabilities [...]

Intertek launches unique pharmaceutical nuclear magnetic resonance spectroscopy (NMR) through its accredited facility

Manchester, United Kingdom – Intertek, a leading quality solutions provider to industries worldwide, announces the launch of an industry-unique high resolution pharmaceutical Nuclear Magnetic Resonance (NMR) capability. The facility is Good Manufacturing Practice (cGMP) compliant and available through Intertek’s existing centre of excellence for NMR spectroscopy and analytical services, located in Manchester, UK. The installation [...]

Thermo Fisher Scientific Signs Exclusive Global Distribution Agreement with NewLab Engineering for Forensic Sample Processing Technology

CARLSBAD, Calif. -- Thermo Fisher Scientific has signed an agreement with NewLab Engineering, a subsidiary of COPAN Italia, for the exclusive global rights to distribute Card Processing Automation (CPA) technology, which is designed to prepare DNA samples for human identification in forensic, paternity and research laboratories. Under the agreement, Thermo Fisher is the sole distributor [...]

Apollo Hospitals Launches Strand’s Clinical Genomic Tests for Personalized Medicine

Hyderabad -- Apollo Hospitals announced the launch of cutting-edge clinical genomic tests from the Strand Center for Genomics and Personalized Medicine, a part of Strand Life Sciences across its hospital network. These tests in oncology, cardiovascular, heritable eye diseases and rare genetic disorders shall be integrated into clinical practice by Apollo’s subsidiary, Sapien Biosciences in [...]

Simulations Plus to Acquire Cognigen Corporation

LANCASTER, Calif.-- Simulations Plus, Inc. (NASDAQ:SLP), a leading provider of simulation and modeling software for pharmaceutical discovery and development, today announced that it has entered into an Agreement and Plan of Merger (the “Agreement”) with Cognigen Corporation of Buffalo, New York. Pursuant to the Agreement, upon closing, Cognigen will become a wholly-owned subsidiary of Simulations [...]

QIAGEN adds promising genomic biomarkers for assessing prognosis in treatment of blood cancers to Personalized Healthcare pipeline

HILDEN, Germany, and MARSEILLE, France -- QIAGEN N.V. (NASDAQ: QGEN; Frankfurt Prime Standard: QIA) today announced it has acquired an exclusive global license to the biomarker SF3B1 from the University of Tokyo. SF3B1 is believed to play a critical role in the prognosis of patients with myelodysplastic syndromes (MDS), a group of hematological cancers in [...]

Cypher Genomics and Illumina Enter Agreement to Facilitate Genomic Biomarker Discovery

SAN DIEGO -- Cypher Genomics, Inc., the genome informatics company, announced today a co-promotion agreement with Illumina to facilitate the development of genomic-based biomarkers from whole genome sequence data for precision medicine and clinical trials. Cypher Genomics and Illumina will jointly offer pharmaceutical companies, through Illumina's sales force, a solution including Illumina's market leading sequencing [...]

Access IBO on Knowledge Center